Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samy Suissa

Showing results (1-10 of 444) with videos related to

Pageof 45
Sort By:
The European Respiratory Journal|June 24, 2017
Run-in bias in randomised trials: the case of COPD medicationsSamy Suissa
American Journal of Respiratory and Critical Care Medicine|May 13, 2020
Mortality in IMPACT: Confounded by Asthma?Samy Suissa
The New England Journal of Medicine|September 1, 2016
Indacaterol-Glycopyrronium for COPDSamy Suissa
The European Respiratory Journal|September 7, 2019
Inhaled corticosteroids and pneumonia mortality in COPD patientsSamy Suissa
American Journal of Respiratory and Critical Care Medicine|November 7, 2008
Methodologic shortcomings of the INSPIRE randomized trialSamy Suissa
JAMA|December 29, 2005
Risk-treatment mismatch for heart failureSamy Suissa
Rambam Maimonides Medical Journal|August 5, 2015
The Number Needed to Treat: 25 Years of Trials and Tribulations in Clinical ResearchSamy Suissa
Diabetes Care|December 22, 2017
Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias?Samy Suissa
The New England Journal of Medicine|July 24, 2009
Calculation of number needed to treatSamy Suissa
The New England Journal of Medicine|December 29, 2016
Effectiveness of Fluticasone Furoate-Vilanterol in COPDSamy Suissa
Pageof 45

Showing results (1-10 of 444) with videos related to

Sort By:
Pageof 45
The European Respiratory Journal|June 24, 2017
Run-in bias in randomised trials: the case of COPD medicationsSamy Suissa
American Journal of Respiratory and Critical Care Medicine|May 13, 2020
Mortality in IMPACT: Confounded by Asthma?Samy Suissa
The New England Journal of Medicine|September 1, 2016
Indacaterol-Glycopyrronium for COPDSamy Suissa
The European Respiratory Journal|September 7, 2019
Inhaled corticosteroids and pneumonia mortality in COPD patientsSamy Suissa
American Journal of Respiratory and Critical Care Medicine|November 7, 2008
Methodologic shortcomings of the INSPIRE randomized trialSamy Suissa
JAMA|December 29, 2005
Risk-treatment mismatch for heart failureSamy Suissa
Rambam Maimonides Medical Journal|August 5, 2015
The Number Needed to Treat: 25 Years of Trials and Tribulations in Clinical ResearchSamy Suissa
Diabetes Care|December 22, 2017
Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias?Samy Suissa
The New England Journal of Medicine|July 24, 2009
Calculation of number needed to treatSamy Suissa
The New England Journal of Medicine|December 29, 2016
Effectiveness of Fluticasone Furoate-Vilanterol in COPDSamy Suissa
Pageof 45